News
El Mundo on MSN37m
FDA OKs trial of pig livers as dialysis-like treatment for liver failureU.S. researchers will soon test whether livers from a gene-edited pig could treat people with sudden liver failure — by temporarily filtering their blood so their own organ can rest and maybe heal.
Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company advancing novel solutions in immunology and oncology, today announced the appointment of Vincent LoPriore, Founder of Gravitas ...
Initiation by Merck of a Phase 2 trial in Alzheimer’s disease with partnered α7 nicotinic acetylcholine receptor PAM MK-1167 highlights company’s ...
As nearly 800,000 Americans face death or permanent disability each year due to diagnostic errors?with women and minorities 30% more likely to be misdiagnosed than white men?it's clear that the U.S.
Colossal Biosciences, an American biotechnology company, announced the "de-extinction" of the dire wolf, a prehistoric wolf species that died out more than 10,000 years ago, in April 2025. Three pups ...
Michael Kratsios, the newly-confirmed director of tech and science policy, introduced a strategy to boost American innovation through deregulation and ...
Popular Western medicines for diseases including cancer and diabetes have been caught in the escalating U.S.-China trade war, a Reuters review of Chinese regulator data showed, and threaten to add to ...
10h
Vietnam Investment Review on MSNPRISM BioLab and Elix Partner to Advance AI Driven Drug DiscoveryPRISM BioLab, Co. Ltd. ("PRISM BioLab"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced ...
The moves, announced Monday in the Federal Register, are a precursor to imposing tariffs and threaten to broaden the president’s sweeping US trade war ...
The much-publicized introduction of genetically modified cubs that share features of extinct dire wolves sparked claims ...
As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.
Expiring patents can be a catalyst for M&A in the life sciences industry as pharmaceutical and biotechnology companies seek ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results